The path to personalized cancer treatment

Researchers identify genetic markers of drug sensitivity in cancer cells

2012-03-29

(Press-News.org) In the largest study of its kind, researchers have profiled genetic changes in cancer with drug sensitivity in order to develop a personalised approach to cancer treatments. The study is published in Nature on Thursday 29 March 2012.

The team uncovered hundreds of associations between mutations in cancer genes and sensitivity to anticancer drugs. One of the key responses the team found was that cells from a childhood bone cancer, Ewing's sarcoma, respond to a drug that is currently used in the treatment of breast and ovarian cancers. The lowered toxicity of this treatment may mean it is a safer alternative therapy for children and young adults with this aggressive cancer.

There is an intimate relationship between the way a drug works and the genetic changes present in cancers. This study found that sensitivity to most anti-cancer drugs is influenced by mutations in cancer genes and establishes the utility of using large-scale studies to identify these associations and build them into improved patient treatment.

"Our key focus is to find how to use cancer therapeutics in the most effective way by correctly targeting patients that are most likely to respond to a specific therapy," explains Dr Mathew Garnett, first author from the Wellcome Trust Sanger Institute. "We studied how genetic changes in a panel of >600 cancer cell lines effects responses to 130 anti-cancer drugs, making it the largest study of this type to date."

The team identified biological markers of drug sensitivity to a broad range of cancer drugs. Most of the cancer genes analysed, including those that are not known directs targets of the drugs tested, were associated with either sensitivity or resistance to at least one of the drugs analysed.

"Our research has taken us down unknown paths to find associations that are completely novel," says Dr Cyril Benes, senior author from Massachusetts General Hospital Cancer Centre. "We have identified hundreds of associations, many of which we still don't fully understand. We identified a novel indication for the use of PARP inhibitors, anti-cancer drugs currently used to treat breast and ovarian cancers, for the treatment of Ewing's sarcoma."

Ewing's sarcoma is a cancer of children and young adults with a 15% five-year survival rate in patients where the cancer has spread or they have relapsed after chemotherapy. The use of PARP inhibitors could represent a new treatment option for Ewing's sarcoma patients and these compounds will now be tested in clinical trials to assess their therapeutic benefit.

"Advances in next-generation sequencing technologies are already being translated into the large-scale detection of cancer gene mutations in the clinic," says Dr Ultan McDermott, senior author from the Wellcome Trust Sanger Institute. "There is a compelling need to identify, in a systematic fashion, whether observed mutations affect the likelihood of a patient's response to a given drug treatment. We have therefore developed a unique online open-access resource for the research and medical community that can be used to optimize the clinical application of cancer drugs as well as the design of clinical trials of investigational compounds being developed as treatments."

The team hopes their open-access database will be an important resource for the cancer research community and which will ultimately lead to improved treatments for patients. This research program is a unique Wellcome Trust funded 5-year collaboration between The Cancer Genome Project at the Wellcome Trust Sanger Institute and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center.

"Our work is helping to move cancer therapeutics away from the conventional tissue-based treatment to a more molecular-based treatment," says Professor Daniel Haber, senior author from Massachusetts General Hospital Cancer Centre. "The next steps for this collaborative project are to evaluate some of the key findings using tumour samples and test new candidate therapeutic strategies in clinical trials so we can hopefully improve the way we treat cancer patients. We are continuing our screening effort, in particular using drug combinations to discover innovative and better therapeutic options."

### Notes to Editors Publication Details Garnett et al 'Systematic identification of genomicmarkers of drug sensitivity in cancer cells' Published in Nature doi:10.1038/nature11005

Funding This work was supported by a grant from the WellcomeTrust and by grants from the National Institutes of Health. S.R. is supported by a Physician-Scientist Early Career Award from the Howard Hughes Medical Institute. U.M. is supported by a Cancer Research UK Clinician Scientist Fellowship.

Participating Centres A list of participating centres can be found in the paper

Selected Websites Massachusetts General Hospital founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $750 million and major research centers in AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, transplantation biology and photomedicine. http://www.massgeneral.org

The Wellcome Trust Sanger Institute is one of the world's leading genome centres. Through its ability to conduct research at scale, it is able to engage in bold and long-term exploratory projects that are designed to influence and empower medical science globally. Institute research findings, generated through its own research programmes and through its leading role in international consortia, are being used to develop new diagnostics and treatments for human disease. http://www.sanger.ac.uk

The Wellcome Trust is a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. We support the brightest minds in biomedical research and the medical humanities. Our breadth of support includes public engagement, education and the application of research to improve health. We are independent of both political and commercial interests. http://www.wellcome.ac.uk

ELSE PRESS RELEASES FROM THIS DATE:

Genome study confirms immune system link to disfiguring leg swelling

2012-03-29

Genetic variants in a region of the genome linked to our immune response have been linked to increased risk of podoconiosis, a disfiguring and disabling leg swelling caused by an abnormal reaction to the minerals found in soil. An estimated 4 million people worldwide suffer from the condition. In a study published today in the New England Journal of Medicine, researchers funded by the Wellcome Trust and the Association of Physicians of Great Britain and Ireland compared the genomes of 194 people affected by the disease from southern Ethiopia against 203 people who were ...

Dealing With Extra Attention After Breast Augmentation

2012-03-29

If you are a woman who has always felt cursed with small breasts, part of your motivation for getting breast augmentation was likely to get more attention from men. But how do you respond if you suddenly suffer from literally an embarrassment of riches? Ignore Random Catcalls--You will likely get a loft of random male attention on the street. This is annoying, but a fact of life for any pretty girl, and likely you were not a complete stranger to it before. Any time men get together, they are always looking for diversion in the form of an attractive woman, and their catcalls ...

Neutrons uncover new density waves in fermion liquids

2012-03-29

Scientists working at the Institut Laue-Langevin, one of the world's leading centres for neutron science, have carried out the first investigation of two-dimensional fermion liquids using neutron scattering, and discovered a new type of very short wave-length density wave. The team believe their discovery, published in Nature, will interest researchers looking at electronic systems, since high temperature superconductivity could result from this type of density fluctuations. Fermi liquids are composed of strongly interacting fermion particles, a group that includes quarks, ...

Beyond GDP: Experts preview 'Inclusive Wealth' index at Planet under Pressure conference

2012-03-29

Brazil and India pay a high price for rapid economic growth, according to experts speaking at a major international meeting in London, Planet Under Pressure. Between 1990 and 2008, the wealth of these two countries as measured by GDP per capita rose 34% and 120% respectively. But a myopic focus on economic capital is flawed, scientists and economists at the conference argue. Natural capital, the sum of a country's assets, from forests to fossil fuels and minerals, declined 46% in Brazil and 31% in India, according to a new "Inclusive Wealth Indicator" designed to augment ...

NY Castle Doctrine Laws Provide Defense Against Home Intruders

2012-03-29

Similar to Englishmen in the 17th century, most New Yorkers probably consider their home to be their castle -- a refuge from the world. It is human nature to want to protect our "castles" from intruders. Perhaps rather unsurprisingly, this concept has a legal name called the Castle Doctrine. It is not a defined law, but a set of principles that has been adopted as some form of law in most states, including New York. Castle Doctrine laws allow people to use force, including deadly force if necessary, to protect themselves from intruders into their home, vehicles ...

San Gabriel Law Firm Helps Community In and Out of the Courtroom

2012-03-29

The Law Offices of Scott Warmuth believes in serving the community through dedicated and professional legal services in the areas of personal injury, immigration, and elder abuse. Representing Southern Californians with easily accessible offices in East and West San Gabriel Valley, the multicultural law firm provides flexibility to its clients by offering services in Mandarin Chinese, Cantonese Chinese, Taiwanese Chinese, English, and Spanish. Over the years, the firm has secured favorable settlements in hundreds of cases and have successfully filed hundreds of visa petitions. ...

Exploding dinosaur hypothesis implodes

2012-03-29

The pregnant ichthyosaur female from Holzmaden (Germany) that perished 182 million years ago puzzled researchers for quite some time: The skeleton of the extinct marine reptile is almost immaculately preserved and the fossilized bones of the mother animal lie largely in their anatomical position. The bones of the ichthyosaur embryos, however, are a different story: For the most part, they lie scattered outside the body of the mother. Such peculiar bone arrangements are repeatedly found in ichthyosaur skeletons. According to the broadly accepted scientific doctrine, this ...

Defective Metal-on-Metal Hip Implants Take a Heavy Toll on Patients

2012-03-29

Every year, an estimated 250,000 Americans undergo a procedure to replace a damaged hip joint. The new, man-made joints implanted are meant to last problem-free for 15 years or more; yet, in one of the most endemic medical device fiascos in recent memory, one entire category of hip implants is failing at an incredible rate, causing widespread and devastating health consequences. An Overview of Metal-on-Metal Hip Replacements An artificial hip implant consists of two components: a socket, and a ball attached to the top of the femur bone that fits inside the socket. ...

Major networking opportunity

2012-03-29

Like people bustling around busy cities, the thousands of molecules inside our cells are constantly interacting with each other: turning each other on or off, working together, splitting up and networking. Understanding the countless ways in which they do so is a major challenge in biology, but it is fundamental to understanding life. Scientists at the European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) and colleagues in the International Molecular Exchange (IMEx) consortium are rising to the challenge by offering researchers a freely available ...

CPIC to Depopulate List of Insured Families

2012-03-29

Some Florida homeowners insured through the Citizens Property Insurance Corporation (CPIC) may receive some surprising offers from private insurance companies in the coming months. The Citizens Property Insurance Corporation is the insurer of last resort in the state of Florida. It is trying to depopulate its list of insured homeowners by encouraging private insurance companies, known as takeout companies, to take over their policies. The private insurance companies that qualify as takeout companies must be licensed and approved for Florida operation by the Office ...

The path to personalized cancer treatment

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: